EUVIMEDEUVIMED entdecken
Crossref

ZNF671 methylation is a potential regression predictor of cervical intraepithelial neoplasia grade 3 in the colposcopy-to-conization interval

Yan Chen, Xiang Li, Puxiang Chen, Zhenzhen Yin, Peng Zhu, Linya Zhang, Shu Li, Yuhang An, Waner Wu, Ding Yuan, Qing Li

Pathology - Research and Practice · 2025

DOI: 10.1016/j.prp.2025.156116 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pathology - Research and Practice, 2025. Verfasst von Yan Chen und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Pharmacology, Xiangya Hospital, Central South University, 87 Xiangya Road, Changsha 410008, PR China; Institute of Clinical Ph…. Hauptthemen laut MEDLINE: Uterine Cervical Dysplasia, Uterine Cervical Neoplasms, DNA Methylation, Biomarkers, Tumor. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 32 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Hunan Provincial Natural Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVE: Despite the high risk of cervical intraepithelial neoplasia grade 3 (CIN3) progressing to cervical cancer, approximately 50 percent of CIN3 lesions were overtreated. Furthermore, CIN3 patients who underwent surgery experienced complications and adverse obstetric outcomes. Therefore, exploring reliable biomarkers to differentiate regressing CIN3 lesions from persistent ones is imperative to preserve female fertility. METHODS: This study evaluated the association between the methylation level of zinc finger protein 671 (ZNF671m) and the regression of CIN3 lesions by examining the postoperative pathology of the cones removed by cold knife conization (CKC) or loop electrosurgical excision procedure (LEEP). RESULTS: In the analysis of 127 cervical scraping cells from CIN3 patients, negative ZNF671m results were significantly associated with downgraded postoperative pathology (OR = 0.225, 95 % CI: 0.084-0.599). Compared to the overall (CKC and LEEP) group, the predictive performance of ZNF671m in the CKC subgroup was improved by 58.7 % (OR = 0.093, 95 % CI: 0.018-0.480). Our results showed that the ZNF671m/cytology/HPV16/18 combination (OR = 0.033, 95 % CI: 0.003-0.376) improved the accuracy of detecting cervical intraepithelial neoplasia grade 1 or less (CIN1-) in the CKC subgroup. However, none of the tests could distinguish the postoperative pathology CIN1- from CIN2+ in the LEEP group. CONCLUSION: These results support that ZNF671m has the potential to predict the regression of CIN3 lesions, and the improved predictive performance of the ZNF671m/cytology/HPV16/18 combination may inform individualized treatment of CIN3 patients planning to undergo CKC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Uterine Cervical DysplasiaUterine Cervical NeoplasmsDNA MethylationBiomarkers, TumorHumansFemaleAdultConizationColposcopyMiddle AgedYoung AdultPapillomavirus InfectionsNeoplasm Grading

Stichwörter der Autor:innen

CIN3DowngradeMethylationRegressionZNF671

Substanzen

Biomarkers, Tumor

Autor:innen und Institutionen

  • Department of Clinical Pharmacology, Xiangya Hospital, Central South University, 87 Xiangya Road, Changsha 410008, PR China; Institute of Clinical Pharmacology, Central South University, Hunan Key Laboratory of Pharmaco…
  • Department of Gynecology, The Third Xiangya Hospital, Central South University, 138 Tong zipo Road, Changsha 410013, PR China.
  • Department of Gynecology and Obstetrics, The Second Xiangya Hospital, Central South University, 139 Renmin Road, Changsha 410011, PR China.
  • Department of Obstetrics and Gynecology, Loudi Central Hospital, 51 Chang Qing Road, Loudi 417000, PR China.
  • Xiangya Medical Laboratory, Central South University, 110 Xiangya Road, Changsha 410078, PR China.
  • Health Management Center, Xiangya Hospital, Central South University, 87 Xiangya Road, Changsha 410008, PR China. Electronic address: 13707481274@163.com.

Förderung

  • National Natural Science Foundation of China
  • Hunan Provincial Natural Science Foundation

Zitieren

APA

Chen, Y., Li, X., Chen, P., Yin, Z., Zhu, P., Zhang, L., Li, S., An, Y., Wu, W., Yuan, D., & Li, Q. (2025). ZNF671 methylation is a potential regression predictor of cervical intraepithelial neoplasia grade 3 in the colposcopy-to-conization interval. Pathology - Research and Practice. https://doi.org/10.1016/j.prp.2025.156116

Vancouver

Chen Y, Li X, Chen P, Yin Z, Zhu P, Zhang L, et al. ZNF671 methylation is a potential regression predictor of cervical intraepithelial neoplasia grade 3 in the colposcopy-to-conization interval. Pathology - Research and Practice. 2025. doi:10.1016/j.prp.2025.156116

BibTeX
@article{Chen2025,
  author = {Chen, Yan and Li, Xiang and Chen, Puxiang and Yin, Zhenzhen and Zhu, Peng and Zhang, Linya and Li, Shu and An, Yuhang and Wu, Waner and Yuan, Ding and Li, Qing},
  title = {ZNF671 methylation is a potential regression predictor of cervical intraepithelial neoplasia grade 3 in the colposcopy-to-conization interval},
  journal = {Pathology - Research and Practice},
  year = {2025},
  doi = {10.1016/j.prp.2025.156116}
}
Kostenlos starten →